We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
113 hedge funds and large institutions have $366M invested in Esperion Therapeutics in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
27% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 30
7% less funds holding
Funds holding: 121 → 113 (-8)
7% less capital invested
Capital invested by funds: $392M → $366M (-$26.1M)
15% less call options, than puts
Call options by funds: $3.62M | Put options by funds: $4.24M
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
Holders
113
Holders Change
-8
Holders Change %
-6.61%
% of All Funds
2.97%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
38
Reduced
30
Closed
28
Calls
$3.62M
Puts
$4.24M
Net Calls
-$621K
Net Calls Change
-$2.32M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$9.11M |
| 2 |
State Street
Boston,
Massachusetts
|
+$8.82M |
| 3 |
CCI
Columbus Circle Investors
|
+$7.96M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.95M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$5.64M |
